Marchex, Inc. Files Form 8-K Disclosing Entry into Material Definitive Agreement
SEATTLE, WA – April 15, 2026 – Marchex, Inc. (NASDAQ: MCHX), a leading provider of prepackaged software services, has filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) announcing that the company has entered into a material definitive agreement. This filing comes on the heels of prior disclosures in Marchex’s 2025 Annual Report on Form 10-K, indicating that the company was in the process of resolving a significant civil action.
Key Highlights for Investors
- Material Definitive Agreement Entered: Marchex has formally entered into a significant legal agreement, as disclosed under Item 1.01 of the Form 8-K. While the filing references a settlement of a civil action, the specific counterparties, financial terms, or business implications of the agreement are not detailed in the public document.
- Potential Legal and Financial Impact: The company’s ongoing legal matters and the settlement of the referenced civil action could have material implications on Marchex’s financial statements, contingent liabilities, and future earnings. Investors should be aware that the resolution of litigation can sometimes lead to one-time charges, ongoing payment obligations, or other material effects on shareholder value.
- Regulatory Compliance and Transparency: By filing the 8-K, Marchex demonstrates its commitment to transparency and regulatory compliance, ensuring that shareholders and the market are kept informed of events that could impact the company’s valuation.
- Class B Common Stock: The filing confirms that Marchex’s Class B Common Stock continues to trade under the symbol MCHX on the Nasdaq Global Select Market.
What Shareholders Need to Know
- Potential Price Sensitivity: The settlement of a material lawsuit could be price sensitive, depending on the financial magnitude and strategic implications of the agreement. Such settlements can either remove legal overhangs, potentially boosting investor confidence, or introduce new financial burdens, which could negatively impact share prices.
- No Indication of Emerging Growth Status: Marchex has indicated that it is not considered an emerging growth company, which means it is subject to the full reporting and compliance requirements of the SEC.
- No Other Simultaneous Communications or Offers: The company has confirmed that it is not simultaneously making written or soliciting communications, nor is it engaged in pre-commencement tender or issuer tender offers. This reduces the likelihood of additional immediate capital market transactions.
Corporate Information
- Business Address: 1200 Fifth Ave, Suite 1300, Seattle, WA 98101
- Business Phone: (206) 331-3300
- State of Incorporation: Delaware
- SEC File Number: 000-50658
- Fiscal Year End: December 31
The filing is signed on behalf of Marchex, Inc. by the Corporate Secretary, reflecting the company’s standard governance and reporting procedures.
Investor Takeaway
The announcement of a material definitive agreement, specifically relating to the settlement of a significant civil action, is a potentially price-moving event. Investors should monitor subsequent disclosures from the company for further details regarding the financial and strategic impact of this settlement. Depending on the terms and the broader context, the resolution of legal disputes can have meaningful ramifications for a company’s risk profile and financial outlook.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult the official SEC filings and their financial advisors before making investment decisions related to Marchex, Inc.
View MARCHEX INC Historical chart here
